Drug Topics

JUNE 11, 2025

This led researchers to explore a specific region of the world in order to better document patients’ understanding of the disease. The prevalence of psoriasis in the Gulf countries is not well-documented; however, recent studies suggested that psoriasis affects 0.5%-5.3%

Immunization 315

Immunization Documentation Specialty Pharmacies Compounding 315

PQA

JUNE 27, 2024

The use of specialty medicine has grown rapidly in recent decades, fueling parallel growth in the number of specialty pharmacies that serve patients who are prescribed specialty medications. Results of this work were published in the Journal of Managed Care & Specialty Pharmacy in October 2022.

Specialty Pharmacies 40

Specialty Pharmacies Communication Packaging Documentation 40

PQA

SEPTEMBER 30, 2024

Today, we published the 2024 PQA Annual Report, which documents our progress towards our strategic goals. Successfully piloting pharmacy measure concepts focused on blood pressure and A1c improvement and control. Successfully piloting PQA’s endorsed measure focused on specialty pharmacy turnaround time.

Specialty Pharmacies 52

Specialty Pharmacies Documentation Communication 52

PQA

MARCH 8, 2024

Ensuring the quality of medication use is critically important for rare disease patients, payers, clinicians, specialty pharmacies and everyone with a role in the care process. If you have questions or would like to be involved, email us at Communications@PQAalliance.org. prior to the PQA Leadership Summit.

Community Pharmacies 52

Community Pharmacies Specialty Pharmacies Independent Pharmacies Documentation 52

PQA

FEBRUARY 23, 2023

The Specialty Pharmacy Abandonment Rate TEP will define a measure around primary abandonment rate of specialty pharmacy prescriptions. The Health Equity TEP will review how PQA measures can be a tool to foster health equity by producing recommendations related to stratification for quality measures.

Specialty Pharmacies 40

Specialty Pharmacies Documentation Communication 40

Drug Topics

JULY 8, 2025

TCSs are the first-line anti-inflammatory treatment and their effectiveness and safety have been well documented.” The next step consists of treatment with topical anti-inflammatory therapies. Above all other medication classes and formulations, TCSs have been deemed as the most important pharmacotherapy in the treatment of AD.

Vaccines 466

Vaccines Specialty Pharmacies Compounding Communication 466

Pharmacy Times

JULY 9, 2025

Autism Spectrum Disorder (ASD) impacts social communication, behavior, and daily functioning. SHOW MORE Discover how vitamin D supplementation may reduce Autism Spectrum Disorder symptoms and improve overall functioning in children with ASD. 4 Despite promising findings, evidence remains mixed.

Compounding Pharmacies 100

Compounding Pharmacies Immunization Specialty Pharmacies Hospitals 100